Stellantis Shifts to Tesla’s EV Charging Standardby Lilu Anderson 12.02.2024Stellantis has announced it will adopt Tesla's North American Charging Standard, solidifying Tesla's dominance in the EV charging market. This ...
TOP Financial Group’s $5M Fundraising Gamble: A Bold Move for Growthby Mark Eisenberg 12.02.2024Hong Kong-based online brokerage firm TOP Financial Group plans to raise $5 million through a registered direct offering. This move ...
Amazon Prime Aims for Record Viewership Surge with NFL Playoff Game Dealby Lilu Anderson 12.02.2024Amazon Prime secures exclusive rights to stream an NFL playoff game in the 2024-2025 season, following successful coverage of Thursday ...
Emerge Commerce: Surge in Shares Post Growth Pivotby Mark Eisenberg 12.02.2024Toronto-based ecommerce brand portfolio, Emerge Commerce, sees surge in shares after achieving positive organic revenue growth in January. Investor confidence ...
Vicinity Motor Corp.: Leading in Canada’s Electric Bus Marketby John Darbie 12.02.2024Vicinity Motor Corp. has secured a major order for electric buses, solidifying its position in Canada's market. Although facing challenges ...
Greenidge Nets $6M Boost: A Turnaround Tale?by John Darbie 12.02.2024Greenidge Generation Holdings secures $6 million investment from Armistice Capital to drive growth and expand its power centers and bitcoin ...
FDA Clears T2 Biosystems’ Key Update in Sepsis Battleby Lilu Anderson 12.02.2024T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...
WiSA Technologies Eyes $10M Boost: Is It Enough?by Mark Eisenberg 12.02.2024WiSA Technologies, Inc. has priced its public offering at approximately $10 million as part of its expansion plans in the ...
Liberia & Guinea’s $5B Leap with Liberty Corridor: A Game-Changerby John Darbie 12.02.2024Mining billionaire Robert Friedland's company, HPX, is partnering with Liberia's government and Guma Africa Group for a $5 billion infrastructure ...
Gilead Acquires CymaBay: Liver Cure Leap?by Mark Eisenberg 12.02.2024Gilead Sciences acquires CymaBay Therapeutics for $4.3 billion to expand its liver disease portfolio, including access to potential treatment for ...